A <i>Gata3</i> enhancer necessary for ILC2 development and function.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 34353913.
- Also identified by DOI 10.1073/pnas.2106311118 and PMC identifier 8364216.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The type 2 helper effector program is driven by the master transcription factor GATA3 and can be expressed by subsets of both innate lymphoid cells (ILCs) and adaptive CD4<sup>+</sup> T helper (Th) cells. While ILC2s and Th2 cells acquire their type 2 differentiation program under very different contexts, the distinct regulatory mechanisms governing this common program are only partially understood. Here we show that the differentiation of ILC2s, and their concomitant high level of GATA3 expression, are controlled by a <i>Gata3</i> enhancer, <i>Gata3</i> +674/762, that plays only a minimal role in Th2 cell differentiation. Mice lacking this enhancer exhibited defects in several but not all type 2 inflammatory responses, depending on the respective degree of ILC2 and Th2 cell involvement. Our study provides molecular insights into the different gene regulatory pathways leading to the acquisition of the GATA3-driven type 2 helper effector program in innate and adaptive lymphocytes.
Medical subject headings
- Enhancer Elements, Genetic
- GATA3 Transcription Factor
- Lymphocytes